Artelo Biosciences (ARTL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.70, -1.46% vs the prior close of $2.74.
- Volume 12.30K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ARTL dips 1.5% to $2.70, a 52-week low, 17 down days in a row. Closed at $2.70, -1.46% vs the prior close of $2.74. Day range $2.70–$2.76, opened at $2.75.
ARTL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ARTL dips 1.5% to $2.70, a 52-week low, 17 down days in a row
- Closed at $2.70, -1.46% vs the prior close of $2.74. Day range $2.70–$2.76, opened at $2.75.
- Volume was 12.30K shares, 0.0x its 50-day average of 610.32K — lighter than usual.
- Price is -47.3% vs its 50-day average ($5.12) and -88.5% vs its 200-day average ($23.56).
- 52-week range $2.70–$179.19; today's close sits at 0% of that range, 98.5% below the 52-week high.
- That makes 17 straight losses.
Oct 15, 2026 — ARTL slides 4.9% to $2.74, a 52-week low, 16 down days in a row
- Closed at $2.74, -4.86% vs the prior close of $2.88. Day range $2.74–$2.90, opened at $2.80.
- Volume was 17.60K shares, 0.0x its 50-day average of 610.22K — lighter than usual.
- Price is -47.4% vs its 50-day average ($5.21) and -88.4% vs its 200-day average ($23.71).
- 52-week range $2.74–$179.19; today's close sits at 0% of that range, 98.5% below the 52-week high.
- That makes 16 straight losses.
Oct 14, 2026 — ARTL slides 3.4% to $2.88, a 52-week low, 15 down days in a row
- Closed at $2.88, -3.36% vs the prior close of $2.98. Day range $2.82–$2.97, opened at $2.95.
- Volume was 43.00K shares, 0.1x its 50-day average of 609.63K — lighter than usual.
- Price is -45.5% vs its 50-day average ($5.29) and -87.9% vs its 200-day average ($23.86).
- 52-week range $2.82–$179.19; today's close sits at 0% of that range, 98.4% below the 52-week high.
- That makes 15 straight losses.
Oct 13, 2026 — ARTL slides 4.2% to $2.98, a 52-week low, 14 down days in a row
- Closed at $2.98, -4.18% vs the prior close of $3.11. Day range $2.92–$3.12, opened at $3.11.
- Volume was 30.80K shares, 0.1x its 50-day average of 609.30K — lighter than usual.
- Price is -44.5% vs its 50-day average ($5.37) and -87.6% vs its 200-day average ($24.05).
- 52-week range $2.92–$179.19; today's close sits at 0% of that range, 98.3% below the 52-week high.
- That makes 14 straight losses.
Oct 12, 2026 — ARTL slides 4.6% to $3.11, a 52-week low, 13 down days in a row
- Closed at $3.11, -4.60% vs the prior close of $3.26. Day range $3.11–$3.25, opened at $3.17.
- Volume was 23.00K shares, 0.0x its 50-day average of 609.12K — lighter than usual.
- Price is -42.8% vs its 50-day average ($5.44) and -87.2% vs its 200-day average ($24.25).
- 52-week range $3.11–$179.19; today's close sits at 0% of that range, 98.3% below the 52-week high.
- That makes 13 straight losses.
Oct 9, 2026 — ARTL slides 3.3% to $3.26, a 52-week low, 12 down days in a row
- Closed at $3.26, -3.26% vs the prior close of $3.37. Day range $3.19–$3.45, opened at $3.44.
- Volume was 45.50K shares, 0.1x its 50-day average of 609.02K — lighter than usual.
- Price is -40.9% vs its 50-day average ($5.52) and -86.7% vs its 200-day average ($24.45).
- 52-week range $3.19–$179.19; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 12 straight losses.
- SEC filings that day: 8-K.
Oct 8, 2026 — ARTL dips 1.2% to $3.37, a 52-week low, 11 down days in a row
- Closed at $3.37, -1.17% vs the prior close of $3.41. Day range $3.37–$3.51, opened at $3.51.
- Volume was 27.20K shares, 0.0x its 50-day average of 609.10K — lighter than usual.
- Price is -39.7% vs its 50-day average ($5.59) and -86.3% vs its 200-day average ($24.65).
- 52-week range $3.33–$179.19; today's close sits at 0% of that range, 98.1% below the 52-week high.
- That makes 11 straight losses.
Oct 7, 2026 — ARTL dips 1.4% to $3.41, a 52-week low, 10 down days in a row
- Closed at $3.41, -1.45% vs the prior close of $3.46. Day range $3.33–$3.55, opened at $3.42.
- Volume was 49.90K shares, 0.1x its 50-day average of 608.39K — lighter than usual.
- Price is -39.6% vs its 50-day average ($5.65) and -86.3% vs its 200-day average ($24.85).
- 52-week range $3.33–$179.19; today's close sits at 0% of that range, 98.1% below the 52-week high.
- That makes 10 straight losses.
Oct 6, 2026 — ARTL dips 1.4% to $3.46, a 52-week low, 9 down days in a row
- Closed at $3.46, -1.42% vs the prior close of $3.51. Day range $3.41–$3.74, opened at $3.65.
- Volume was 74.40K shares, 0.1x its 50-day average of 607.06K — lighter than usual.
- Price is -39.7% vs its 50-day average ($5.74) and -86.2% vs its 200-day average ($25.06).
- 52-week range $3.41–$179.19; today's close sits at 0% of that range, 98.1% below the 52-week high.
- That makes 9 straight losses.
Oct 5, 2026 — ARTL slides 4.6% to $3.51, a 52-week low, 8 down days in a row
- Closed at $3.51, -4.62% vs the prior close of $3.68. Day range $3.50–$3.75, opened at $3.75.
- Volume was 46.90K shares, 0.1x its 50-day average of 606.26K — lighter than usual.
- Price is -40.0% vs its 50-day average ($5.85) and -86.1% vs its 200-day average ($25.29).
- 52-week range $3.45–$179.19; today's close sits at 0% of that range, 98.0% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 — ARTL slides 3.9% to $3.68, a 52-week low, 7 down days in a row
- Closed at $3.68, -3.92% vs the prior close of $3.83. Day range $3.63–$3.85, opened at $3.85.
- Volume was 63.00K shares, 0.1x its 50-day average of 605.13K — lighter than usual.
- Price is -38.3% vs its 50-day average ($5.97) and -85.6% vs its 200-day average ($25.52).
- 52-week range $3.45–$179.19; today's close sits at 0% of that range, 97.9% below the 52-week high.
- That makes 7 straight losses.
ARTL latest news & SEC filings
Every SEC filing by or about ARTL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 20, 2026 · Form 10-Q/A — Quarterly report (amended)
Amended quarterly report
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.43M (prior year -$3.22M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.89 (prior year -$16.86) (loss narrowed vs Jun 30, 2025)
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jul 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Things to know before you trade ARTL
- Last results release: Mar 17, 2026 (8-K Item 2.02). Previous ones: Jul 11, 2025, Jan 14, 2020, Jul 15, 2019. Based on that rhythm, the next report is likely around Jun 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 8.69% (largest 76.1%). That is a volatile stock.
- Liquidity: about 1.38M shares (≈$3.74M) trade per day on average.
- 52-week position: $2.70 vs a range of $2.70–$179.19 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:9 on Aug 31, 2026, 1:3 on Mar 10, 2026, 1:6 on Jun 13, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 9, 2026; 8-K Aug 27, 2026; 10-Q Aug 12, 2026.
- Share count: 4.60M shares outstanding (Aug 11, 2026), +247.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ARTL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.75 | 2.76 | 2.70 | 2.70 | 12.30K |
| Oct 15, 2026 | 2.80 | 2.90 | 2.74 | 2.74 | 17.60K |
| Oct 14, 2026 | 2.95 | 2.97 | 2.82 | 2.88 | 43.00K |
| Oct 13, 2026 | 3.11 | 3.12 | 2.92 | 2.98 | 30.80K |
| Oct 12, 2026 | 3.17 | 3.25 | 3.11 | 3.11 | 23.00K |
| Oct 9, 2026 | 3.44 | 3.45 | 3.19 | 3.26 | 45.50K |
| Oct 8, 2026 | 3.51 | 3.51 | 3.37 | 3.37 | 27.20K |
| Oct 7, 2026 | 3.42 | 3.55 | 3.33 | 3.41 | 49.90K |
| Oct 6, 2026 | 3.65 | 3.74 | 3.41 | 3.46 | 74.40K |
| Oct 5, 2026 | 3.75 | 3.75 | 3.50 | 3.51 | 46.90K |
| Oct 2, 2026 | 3.85 | 3.85 | 3.63 | 3.68 | 63.00K |
| Oct 1, 2026 | 4.04 | 4.07 | 3.80 | 3.83 | 92.40K |
| Sep 30, 2026 | 4.06 | 4.30 | 3.95 | 4.04 | 67.70K |
| Sep 29, 2026 | 4.20 | 4.30 | 4.05 | 4.07 | 87.00K |
| Sep 28, 2026 | 4.44 | 4.55 | 4.25 | 4.30 | 153.50K |
| Sep 25, 2026 | 4.93 | 4.93 | 4.43 | 4.54 | 256.50K |
| Sep 24, 2026 | 4.87 | 5.35 | 4.51 | 5.17 | 1.05M |
| Sep 23, 2026 | 4.03 | 15.73 | 3.90 | 7.31 | 25.13M |
| Sep 22, 2026 | 4.14 | 4.20 | 3.86 | 4.15 | 324.30K |
| Sep 21, 2026 | 3.89 | 4.19 | 3.88 | 4.10 | 71.80K |
About Artelo Biosciences
Artelo Biosciences (ARTL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOLANA BEACH, CA. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1621221.
ARTL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Douglas Blayney | Director | Jul 21, 2026 |
| Robert Martin Emanuele | Director | Jul 21, 2026 |
| Tamara A Favorito | Director | Jul 21, 2026 |
| Gregory D. Gorgas | Pres, CEO, CFO, Treas & Secr | Feb 2, 2026 |
| Steven Kelly | Director | Jul 21, 2026 |
| Connie Matsui | Director | Jul 21, 2026 |
| Gregory Reyes | Director | Jul 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gregory D. Gorgas | Pres, CEO, CFO, Treas & Secr | Feb 2, 2026 |
| Mark Edward Spring | Chief Financial Officer | Feb 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ARTL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-12.88M | -12.52 | $-8.52M |
| Dec 31, 2024 | — | $-9.83M | -18.30 | $-8.35M |
| Dec 31, 2023 | — | $-9.29M | -3.14 | $-8.21M |
| Dec 31, 2022 | — | $-10.08M | — | $-8.01M |
| Dec 31, 2021 | — | $-9.41M | — | — |
Latest balance sheet: total assets $6.46M, total liabilities $1.46M, cash $4.20M (as of Jun 30, 2026).
ARTL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 17, 2026 | 8-K Item 2.02 (results) | $43.65 |
| Jul 11, 2025 | 8-K Item 2.02 (results) | $644.62 |
| Jan 14, 2020 | 8-K Item 2.02 (results) | — |
| Jul 15, 2019 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ARTL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.